Company Overview

ALNYLAM PHARMACEUTICALS, INC.

ALNY
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
3,714M
2025 FY
Net Income
314M
2025 FY
Shares Outstanding
131M
2025 FY
EPS
2.39USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1178670
Exchange
Nasdaq
Location
US